GoodmanS.Towards evidence-based medical statistics; 1: The P value fallacy.Ann Intern Med1999; 130: 995–1004.
2.
FreimanJ.A., ChalmersT.C., SmithH.Jr., KueblerR.R.The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 “negative” trials.N Engl J Med1978; 299: 690–694.
3.
SiegelJ.P.Equivalence and noninferiority trials.Am Heart J2000; 139: S166–170.
4.
GreeneW.L., ConcatoJ., FeinsteinA.R.Claims of equivalence in medical research: are they supported by the evidence?Ann Intern Med2000; 132: 715–722.
5.
GotzscheP.C.Lessons from and cautions about noninferiority and equivalence randomized trials.JAMA2006; 295: 1172–1174.
6.
MylesP.S.What's new in trial design: propensity scores, equivalence, and non-inferiority.J Extra Corpor Technol2009; 41: P6–10.
7.
KaulS., DiamondG.A.Good enough: a primer on the analysis and interpretation of noninferiority trials.Ann Intern Med2006; 145: 62–69.
8.
SerruysP.W., MoriceM-C, KappeteinA.P., ColomboA., HolmesD.R., MackM.J.Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.N Engl J Med2009; 360: 961–972.
9.
GreilichP.E., JessenM.E., SatyanarayanaN., WhittenC.W., NuttallG.A., BeckhamJ.M.The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.Anesth Analg2009; 109: 15–24.
10.
PocockS.J., WareJ.H.Translating statistical findings into plain English.Lancet2009; 373: 1926–1928.